Search clinical trials for: Japanese

Total 2175 results

AstraZeneca

Completed

A Study to Assess the Safety, Tolerability and Pharmacokinetics of Modified-Release Formulations of AZD1446 After Oral Single and Repeated Doses

Healthy

Japan
Pfizer

Completed

Multiple Oral Doses Of PH-797804 In Healthy Japanese Adult Subjects

Healthy

United States
AstraZeneca

Terminated

Safety and Tolerability Study of AZD7762 in Combination With Gemcitabine

Cancer | Solid Tumors | Advanced Solid Malignancies

Japan
Janssen Pharmaceutical K.K.

Completed

Phase III Clinical Trial of Fentanyl Transdermal Matrix Patch, in the Management of Chronic Intractable Pain- Assessment of Effectiveness, Safety and Pharmacokinetics

Pain, Intractable
Sanofi
Regeneron Pharmaceuticals

Completed

A Phase I Study of Intravenous Aflibercept in Combination With S-1 in Japanese Cancer Patients

Neoplasms

Japan
Bristol-Myers Squibb

Completed

A Phase I Study of BMS-641988 in Japanese Patients With Castration Resistant Prostate Cancer

Prostate Cancer

Japan
Bristol-Myers Squibb

Completed

Multiple Dose Japanese Bridging Study

Alzheimer Disease

United States
AstraZeneca
Mitsubishi Tanabe Pharma Corporation

Completed

A Study to Investigate the Pharmacodynamic Effect After Four-week Omeprazole Treatment of Non-erosive Reflux Disease in a Japanese Population

Non-erosive Reflux Disease

Japan
Janssen Pharmaceutical K.K.

Completed

Phase II Clinical Trial of Fentanyl Transdermal Matrix Patch, in the Management of Cancer Pain- Assessment of Effectiveness, Safety and Pharmacokinetics -

Pain, Intractable
AstraZeneca
Mitsubishi Tanabe Pharma Corporation

Completed

Four-week Omeprazole Treatment of Non-erosive Reflux Disease in a Japanese Population

Non-erosive Reflux Disease

Japan
AstraZeneca

Completed

Safety & Efficacy of Symbicort® Turbuhaler® (1, 2, and 4 x 160/4.5 µg Twice Daily) in Japanese Patients With Asthma

Asthma

Japan
AstraZeneca

Completed

Efficacy & Safety of Symbicort® TURBUHALER® 160/4.5 µg Twice Daily & Pulmicort® TURBUHALER® 200 µg Twice Daily + Theolong® Tablet 200 mg Twice Daily in Japanese Asthmatic Patients

Asthma

Japan
Bristol-Myers Squibb

Completed

Safety Study of Multiple-dose of Gamma-secretase Inhibitor in Healthy Male Japanese and Healthy Elderly Japanese (JMAD)

Healthy

Japan
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Study Evaluating The Safety and Tolerability of HTC-867 in Healthy Japanese Subjects

Schizophrenia
Aarhus University Hospital

Completed

Efficacy and Safety of Switching From Retrovir to Tenofovir or Abacavir in HIV-infected Patients (SWAP)

HIV Infections

Denmark
AstraZeneca

Completed

Multiple Ascending Dose Study for AZD 7268 in Japanese Healthy Male Volunteers (JMAD)

Healthy

Japan
AstraZeneca

Completed

AZD Single Ascending Dose Study In Healthy Japanese Subjects (JSAD)

Healthy

United Kingdom
Eli Lilly and Company

Completed

Observational Study in Japanese Type 2 Diabetes Patients (INSIGHTS)

Diabetes Mellitus, Type 2

Japan
AstraZeneca

Terminated

Assess Safety, Tolerability and Pharmacokinetic (PK) of AZD1704 in Healthy Japanese Male and Non-Fertile Female Volunteers

Healthy Volunteers

United Kingdom
Pfizer

Completed

A Phase I, Single Dose Study Of PF-04360365 In Japanese Patients With Mild To Moderate Alzheimer's Disease

Alzheimer's Disease

Japan
AstraZeneca

Terminated

AZD1305 Single and Multiple Ascending Dose Study in Healthy Japanese and Caucasian Subjects (JMAD)

Healthy

United States
AstraZeneca

Completed

A Study to Evaluate Safety and Tolerability After Single Oral Dosing of AZD1656 in Japanese Healthy Volunteers

Healthy Volunteers

United States
AstraZeneca

Terminated

A Single and Multiple Ascending Dose Study With AZD9164 Given for 13 Days in Healthy Male and Female Japanese Subjects (JSMAD)

Healthy

United Kingdom
AstraZeneca

Completed

Safety, Tolerability and Pharmacokinetics of Inhaled Doses of AZD4818 in Healthy Japanese Male Volunteers

Healthy

Japan
ViiV Healthcare
Pfizer

Completed

Investigation Of Safety And Pharmacokinetics Following A Single Oral Dose Of 300 Mg Maraviroc In Healthy Male Japanese Volunteers

Human Immunodeficiency Virus (HIV) Infection

Singapore
Abbott
Abbott Japan Co.,Ltd

Completed

A Study of Single Doses of ABT-072 in Japanese Healthy Male Adults

Hepatitis C

Japan
Wyeth is now a wholly owned subsidiary of Pfizer

Terminated

Study Evaluating FXR-450 in Healthy Japanese Men

Healthy

Japan
Pfizer

Completed

Phase 1, Single and Multiple Doses Study of Sitaxentan in Japanese and Western Subjects

Healthy

United States
AstraZeneca

Completed

Study to Assess the Pharmacodynamics/Pharmacokinetics After Repeated Dosing of D961H 10 mg and Omeprazole 10 mg in Japanese Healthy Male Subjects

Pharmacodynamics Study

Japan
AstraZeneca

Completed

AZD9742 Single and Multiple Ascending Dose Study in Healthy Male and Female Japanese Subjects

Healthy

United States
Mennonite Christian Hospital

Unknown

Seroepidemiology of Japanese Encephalitis Virus Infection in Hualien, Taiwan

Japanese Encephalitis
Society for Advancement of Coronary Intervention...

Unknown

Xience/Promus for Long Coronary Lesion Registry (XILLION)

Long Coronary Artery Disease

Japan
AstraZeneca

Completed

Study to Assess Safety, Tolerability and Pharmacokinetics After Single and Multiple Doses of AZD1446 to Japanese Subject

Healthy

Japan
Society for Advancement of Coronary Intervention...

Unknown

Small Coronary Artery Treated by TAXUS Liberté Registry in Japan (SACRA)

Stable Angina Pectoris | Unstable Angina Pectoris

Japan
Eli Lilly and Company

Completed

Solanezumab Safety Study in Japanese Patients With Alzheimer's Disease

Alzheimer's Disease

Japan
AstraZeneca

Completed

Comparative Efficacy & Safety Study of Esomeprazole Versus Placebo for the Prevention of Gastric and Duodenal Ulcers With NSAID

Osteoarthritis | Rheumatoid Arthritis | Lumbago | Gastric Ulcer | Duodenal Ulcer

Japan
Japanese Society of Intensive Care Medicine

Completed

The Fever and Antipyretic in Critically Illness Evaluation Study (FACE)

Hyperthermia | Fever

Japan, Korea, Republic of
Tibotec Pharmaceuticals, Ireland

Completed

TMC435350-TiDP16-C109: A Safety Study for TMC435350 in an Oral Solution Containing Either 100, 200 or 400 mg Equivalent of TMC435350 or Placebo in Healthy Japanese Male Volunteers

HCV
Centocor, Inc.

Completed

A Study of the Safety and How the Body Effects a Drug CNTO 136 in Healthy Male Japanese and Caucasian Volunteers

Healthy
Pfizer

Completed

A Study To Investigate Safety And Pharmacokinetics Of A Single Dose Of PF-00868554 (Filibuvir) In Japanese Healthy Adult Volunteers

Healthy

Japan
Sanofi

Completed

Japanese Efficacy and Safety Study of Enoxaparin in Patients With Curative Abdominal Cancer Surgery

Abdominal Neoplasms

Japan
AstraZeneca

Completed

AZD2423 Single Ascending Dose Study in Healthy Japanese Subjects (JSAD)

Healthy Volunteer

United Kingdom
InCROM Europe Clinical Research

Completed

Bioequivalence of a Single Subcutaneous Dose of Epoetin Beta in Healthy Japanese and Caucasian Male Subjects

Anaemia | Chronic Kidney Failure
AstraZeneca

Completed

Study to Assess Safety, Tolerability and Pharmacokinetics After Single Dose of AZD2516 to Japanese Healthy Subjects

Healthy

Japan
National Institute of Diabetes and Digestive and...

Completed

Lifestyle Interventions to Reduce Diabetes Risk

Diabetes Mellitus, Type 2 | Glucose Intolerance

United States
The Baruch Padeh Medical Center, Poriya
Rambam Health Care Campus; Soroka University Medical Center

Withdrawn

Comparing the Use of Vitamin c (Ascorbic Acid) in Eye Burn in Subconjunctival Injection to Topical or Oral Treatment.

Burn

Israel
Govind Ballabh Pant Hospital

Completed

Randomized Controlled Trial of Tenofovir in Patients of Reactivation of Hepatitis B Presenting as Acute on Chronic Liver Failure (ACLF)

Hepatitis B | Acute on Chronic Liver Failure

India
AstraZeneca

Withdrawn

Study to Assess Safety and Tolerability of AZD0530 in Combination With Carboplatin and Paclitaxel

Cancer | Non Small Cell Lung Cancer | Epithelial Ovarian Cancer

Japan
Pfizer

Completed

Study Of Single Ascending And Multiple Doses Of PF-04447943 In Japanese Subjects.

Healthy

United States
Novartis

Completed

A Phase I Dose Escalation Study of LBQ707 (Gimatecan) Administered Orally Twice Per Week to Japanese Patients With Advanced Solid Tumors

Advanced Solid Tumors

Japan

3

Subscribe